BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 12850765)

  • 21. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
    Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
    AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS related malignant disease at regional institute of medical sciences.
    Gatphoh ED; Zamzachin G; Devi SB; Punyabati P
    Indian J Pathol Microbiol; 2001 Jan; 44(1):1-4. PubMed ID: 12561985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus-associated neoplasms: epidemiology, pathogenesis, and review of current therapy.
    Aboulafia DM
    Cancer Pract; 1994; 2(4):297-306. PubMed ID: 7858657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS-associated malignancies.
    Akanmu AS
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():57-70. PubMed ID: 18050776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era?
    Clayton A; Mughal T
    Hematol Oncol; 2004 Sep; 22(3):111-20. PubMed ID: 15991221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Kaposi's sarcoma].
    Boué F; Lebbé C
    Bull Cancer; 2003 May; 90(5):393-8. PubMed ID: 12850761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
    Mounier N; Spina M; Gisselbrecht C
    Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
    Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
    Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Update on Kaposi's sarcoma].
    Morand JJ; Lightburn E; Simon F; Patte JH
    Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
    Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D
    Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069
    [No Abstract]   [Full Text] [Related]  

  • 36. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
    J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
    J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
    Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects.
    Levine AM
    Semin Oncol; 2000 Aug; 27(4):442-53. PubMed ID: 10950371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.